These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1909821)

  • 1. Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies.
    Hong F; Shastri KA; Logue GL; Spaulding MB
    Transfusion; 1991 Sep; 31(7):642-7. PubMed ID: 1909821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.
    Vercellotti GM; Hammerschmidt DE; Craddock PR; Jacob HS
    Blood; 1982 Jun; 59(6):1299-1304. PubMed ID: 7082830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of complement by Fluosol attributable to the pluronic detergent micelle structure.
    Ingram DA; Forman MB; Murray JJ
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):456-61. PubMed ID: 7504138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell substitutes and artificial blood.
    Bowman RJ
    Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man.
    Fukushima K; Nakamura M; Hinuma K
    Prog Clin Biol Res; 1983; 122():291-8. PubMed ID: 6878373
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influences of Fluosol-DA infusion on the complement activation and on the blood level of histamine in man].
    Fukushima K; Nakamura M; Hinuma K
    Masui; 1983 Feb; 32(2):192-8. PubMed ID: 6854932
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.
    Freysdottir J; Ormarsdottir S; Sigfusson A
    Clin Exp Immunol; 1993 Nov; 94(2):286-90. PubMed ID: 8222319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
    Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
    J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activation of human complement by polyacrilonitrile dialyzer membrane assayed by complement binding to bystander red cells.
    Shastri KA; Logue GL
    ASAIO J; 1992; 38(1):47-51. PubMed ID: 1554917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc supplementation inhibits complement activation in age-related macular degeneration.
    Smailhodzic D; van Asten F; Blom AM; Mohlin FC; den Hollander AI; van de Ven JP; van Huet RA; Groenewoud JM; Tian Y; Berendschot TT; Lechanteur YT; Fauser S; de Bruijn C; Daha MR; van der Wilt GJ; Hoyng CB; Klevering BJ
    PLoS One; 2014; 9(11):e112682. PubMed ID: 25393287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of complement activation during extracorporeal circulation by measurement of complement split C3d.
    Knudsen F
    Blood Purif; 1987; 5(2-3):162-7. PubMed ID: 3497646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research Group.
    Wall TC; Califf RM; Blankenship J; Talley JD; Tannenbaum M; Schwaiger M; Gacioch G; Cohen MD; Sanz M; Leimberger JD
    Circulation; 1994 Jul; 90(1):114-20. PubMed ID: 8025985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations.
    Hammerschmidt DE; Vercellotti GM
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):431-8. PubMed ID: 3263156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of artificial blood substitute (fluosol-DA 20%) in patients of cerebral ischemia].
    Oda Y; Murata T; Uchida Y; Mori K; Nagasawa S; Naruo Y; Asato R; Handa H
    No Shinkei Geka; 1982 Jun; 10(6):637-44. PubMed ID: 7121730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphology of the pig liver after Fluosol infusion].
    Petutschnigk D; Herrmann M; Hirlinger WK
    Z Mikrosk Anat Forsch; 1980; 94(5):908-12. PubMed ID: 7210801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Fluosol-DA (artificial blood) on clinical chemistry tests and instruments.
    Mullins RE; Hutton PS; Conn RB
    Am J Clin Pathol; 1983 Oct; 80(4):478-83. PubMed ID: 6624711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Fluosol-DA on induction of inhalation anesthesia.
    Chilcoat RT; Gerson JI; Allen FB; Mapleson WW
    Anesth Analg; 1985 Apr; 64(4):405-10. PubMed ID: 3985389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Fluosol-DA on pulmonary vessels.
    Nishimura N; Sugi T; Hiranuma N
    Prog Clin Biol Res; 1983; 122():283-9. PubMed ID: 6878371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.